These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 15500957)

  • 1. Insulin degrading enzyme is expressed in the human cerebrovascular endothelium and in cultured human cerebrovascular endothelial cells.
    Gao W; Eisenhauer PB; Conn K; Lynch JA; Wells JM; Ullman MD; McKee A; Thatte HS; Fine RE
    Neurosci Lett; 2004 Nov; 371(1):6-11. PubMed ID: 15500957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin degrading enzyme is localized predominantly at the cell surface of polarized and unpolarized human cerebrovascular endothelial cell cultures.
    Lynch JA; George AM; Eisenhauer PB; Conn K; Gao W; Carreras I; Wells JM; McKee A; Ullman MD; Fine RE
    J Neurosci Res; 2006 May; 83(7):1262-70. PubMed ID: 16511862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative splicing of human insulin-degrading enzyme yields a novel isoform with a decreased ability to degrade insulin and amyloid beta-protein.
    Farris W; Leissring MA; Hemming ML; Chang AY; Selkoe DJ
    Biochemistry; 2005 May; 44(17):6513-25. PubMed ID: 15850385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of insulin-degrading enzyme in insulin- and atrial natriuretic peptide-sensitive internalization of amyloid-β peptide in mouse brain capillary endothelial cells.
    Ito S; Ohtsuki S; Murata S; Katsukura Y; Suzuki H; Funaki M; Tachikawa M; Terasaki T
    J Alzheimers Dis; 2014; 38(1):185-200. PubMed ID: 23948938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of Abeta degrading enzyme IDE in the cortex of transgenic mice with Alzheimer's disease-like neuropathology.
    Vepsäläinen S; Hiltunen M; Helisalmi S; Wang J; van Groen T; Tanila H; Soininen H
    Neurosci Lett; 2008 Jun; 438(2):216-20. PubMed ID: 18455870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of protein degradation by insulin-degrading enzyme: analysis by small interfering RNA-mediated gene silencing.
    Fawcett J; Permana PA; Levy JL; Duckworth WC
    Arch Biochem Biophys; 2007 Dec; 468(1):128-33. PubMed ID: 17964527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-degrading enzyme.
    Authier F; Posner BI; Bergeron JJ
    Clin Invest Med; 1996 Jun; 19(3):149-60. PubMed ID: 8724818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between insulin-degrading enzyme activity and insulin sensitivity in cell model of insulin-resistance].
    Li CZ; Zhang SH; Shu CD; Ren W
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Feb; 22(2):151-4. PubMed ID: 12390813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-degrading enzyme is differentially expressed and developmentally regulated in various rat tissues.
    Kuo WL; Montag AG; Rosner MR
    Endocrinology; 1993 Feb; 132(2):604-11. PubMed ID: 7678795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide inhibits insulin-degrading enzyme activity and function through S-nitrosylation.
    Cordes CM; Bennett RG; Siford GL; Hamel FG
    Biochem Pharmacol; 2009 Mar; 77(6):1064-73. PubMed ID: 19154729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin degrading enzyme activity selectively decreases in the hippocampal formation of cases at high risk to develop Alzheimer's disease.
    Zhao Z; Xiang Z; Haroutunian V; Buxbaum JD; Stetka B; Pasinetti GM
    Neurobiol Aging; 2007 Jun; 28(6):824-30. PubMed ID: 16769157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexamethasone inhibits insulin binding to insulin-degrading enzyme and cytosolic insulin-binding protein p82.
    Harada S; Smith RM; Hu DQ; Jarett L
    Biochem Biophys Res Commun; 1996 Jan; 218(1):154-8. PubMed ID: 8573122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin: a novel substrate and a modulator of insulin-degrading enzyme activity.
    Ciaccio C; Tundo GR; Grasso G; Spoto G; Marasco D; Ruvo M; Gioia M; Rizzarelli E; Coletta M
    J Mol Biol; 2009 Feb; 385(5):1556-67. PubMed ID: 19073193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence variants of IDE are associated with the extent of beta-amyloid deposition in the Alzheimer's disease brain.
    Blomqvist ME; Chalmers K; Andreasen N; Bogdanovic N; Wilcock GK; Cairns NJ; Feuk L; Brookes AJ; Love S; Blennow K; Kehoe PG; Prince JA
    Neurobiol Aging; 2005 Jun; 26(6):795-802. PubMed ID: 15718037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional and cellular distribution patterns of insulin-degrading enzyme in the adult human brain and pituitary.
    Bernstein HG; Lendeckel U; Bukowska A; Ansorge S; Ernst T; Stauch R; Trübner K; Steiner J; Dobrowolny H; Bogerts B
    J Chem Neuroanat; 2008 Mar; 35(2):216-24. PubMed ID: 18226493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PPARgamma transcriptionally regulates the expression of insulin-degrading enzyme in primary neurons.
    Du J; Zhang L; Liu S; Zhang C; Huang X; Li J; Zhao N; Wang Z
    Biochem Biophys Res Commun; 2009 Jun; 383(4):485-90. PubMed ID: 19383491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter polymorphisms which modulate insulin degrading enzyme expression may increase susceptibility to Alzheimer's disease.
    Zuo X; Jia J
    Brain Res; 2009 Jan; 1249():1-8. PubMed ID: 18996360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ApoE 4 reduces the expression of Abeta degrading enzyme IDE by activating the NMDA receptor in hippocampal neurons.
    Du J; Chang J; Guo S; Zhang Q; Wang Z
    Neurosci Lett; 2009 Oct; 464(2):140-5. PubMed ID: 19616072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of insulin-degrading enzyme by presenilin 1 V97L mutant potentially underlies increased levels of amyloid beta 42.
    Qin W; Jia J
    Eur J Neurosci; 2008 May; 27(9):2425-32. PubMed ID: 18445230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical demonstration of the zinc metalloprotease insulin-degrading enzyme in normal and malignant human breast: correlation with tissue insulin levels.
    Radulescu RT; Hufnagel C; Luppa P; Hellebrand H; Kuo WL; Rosner MR; Harbeck N; Giersig C; Meindl A; Schmitt M; Weirich G
    Int J Oncol; 2007 Jan; 30(1):73-80. PubMed ID: 17143514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.